TABLE 1.
Seroprevalence of anti-C. pneumoniae IgG and IgA in patient collective 2a
| True result | Total no. of samples | Result for IgG test
|
Result for IgA test
|
Total no. of samples | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIF | SeroCP Quant | SeroCP | sELISA | No. positive in rELISA | MIF | SeroCP Quant | SeroCP | |||
| Positive | 58 | + | + | + | + | 39 | + | + | + | 51 |
| 3 | + | + | + | − | 2 | + | − | + | 7 | |
| 1 | + | + | − | + | + | + | − | 1 | ||
| 2 | + | − | + | − | + | − | − | 2 | ||
| 1 | + | − | − | − | ||||||
| Negative | 1 | − | + | + | + | − | + | + | 1 | |
| 1 | − | + | − | − | − | + | − | 1 | ||
| 4 | − | − | + | − | 1 | − | − | − | 17 | |
| 1 | − | − | − | + | 1 | |||||
| 8 | − | − | − | − | 2 | |||||
| % Positive samples | 81 | 80 | 84 | 76 | 56 | 76 | 68 | 74 | ||
a
Eighty samples from collective 2 were analyzed for C. pneumoniae IgA and IgG by the assays indicated. Data were grouped on the basis of the gold standard MIF test.